BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Nippon Kayaku Co., Ltd. 

11-2, Fujimi 1 chome

Chiyoda-ku  Tokyo  102-8172  Japan
Phone: 81-3-3237-5046 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Initiation of a Required Phase 1 Study of Apaziquone in Japan by Nippon Kayaku Co., Ltd. 1/6/2011 9:42:34 AM    More...
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Receipt of $16 Million from Asian Partners, Such As Nippon Kayaku Co., Ltd. Related to Apaziquone Collaboration Agreements Announced in November 2009 1/29/2010 7:55:39 AM    More...
Spectrum Pharmaceuticals, Inc. (SPPI) and Nippon Kayaku Co., Ltd. Enter Collaboration Agreement for Apaziquone in Asian Territories 11/10/2009 9:17:16 AM    More...
BioSphere Medical, Inc. (BSMD) Enters into Exclusive Distribution Agreement with Nippon Kayaku Co., Ltd. for Japanese Market 4/16/2009 8:21:00 AM    More...
Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes 7/17/2008 7:37:51 AM    More...
NeoPharm (NEOL) Says Japan's Nippon Kayaku Co., Ltd. Terminates License Agreement 9/14/2007 8:08:14 AM    More...
Shionogi & Co., Ltd. And Nippon Kayaku Co., Ltd. To Release Cetrotide In Japan 9/21/2006 3:44:33 PM    More...
Spectrum Pharmaceuticals, Inc. (SPPI) Announces A License And Collaboration Agreement For Ozarelix With Nippon Kayaku Co., Ltd. For The Japanese Market 8/4/2006 11:06:54 AM    More...
AEterna Zentaris (AEZS) Enters A License And Collaboration Agreement For Ozarelix With Nippon Kayaku Co., Ltd. For The Japanese Market 8/3/2006 10:39:28 AM    More...
Shionogi & Co., Ltd. And Nippon Kayaku Co., Ltd. Receive Approval For Cetrotide 4/21/2006 10:30:48 AM    More...
12